Praxis Precision Medicines Receives Rare Pediatric Disease and Orphan Drug Designations for Severe Pediatric Epilepsy Programs
January 07, 2021 08:00 ET
|
Praxis Precision Medicines, Inc
FDA grants RPD and ODD for PRAX-222 for treatment of SCN2A-DEE FDA grants RPD for PRAX-562 for treatment of SCN2A-DEE and SCN8A-DEE CAMBRIDGE, Mass., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Praxis...
Brain Scientific To Enter the U.S. Pediatric Market with NeuroCap™ for Children
December 17, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, has announced its next generation...
Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
December 15, 2020 08:30 ET
|
Brain Scientific Inc.
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a...
Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting
December 10, 2020 08:43 ET
|
Trevena Inc.
-- Presentations highlight efficacy of TRV045 in animal models of neuropathic pain and epilepsy TRV045 selectively targets the S1P1 receptor without associated lymphopenia IND filing on track for...
Invitae and Pacific Biosciences Collaborate to Develop Whole Genome Sequencing-Based Assays for Pediatric Epilepsy Diagnostics
October 22, 2020 08:00 ET
|
Pacific Biosciences of California, Inc.
SAN FRANCISCO and MENLO PARK, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Invitae Corporation (NYSE: NVTA), a leading genetics company, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a...
NeuroSigma Receives Bridge Financing from Checkmate Capital
September 21, 2020 11:00 ET
|
Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...
Innovative New Book ‘Spiritual Mazes & Puzzles’ Leads Individuals on Gratifying Path to Understanding God’s Word and America’s History
August 17, 2020 06:10 ET
|
WestBow Press
TUCSON, Ariz., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Enduring constant seizures from epilepsy all her life, author Shelly P. Emerson began to tap into her creative side. She found it therapeutic to draw...
Brain Scientific Updates Disposable EEG Headset Sales Plan, Supply Scale-Up, and IP Status
June 17, 2020 07:00 ET
|
Brain Scientific
3 hospitals place expanded, non-commercial orders for further testing and evaluation“Consider rapid application EEG with disposable, single use caps/ templates...” - American Clinical Neurophysiology...
Brain Scientific Introduces Enhanced NeuroCap™ Disposable EEG Headset
May 28, 2020 07:00 ET
|
Brain Scientific
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC: BRSF), a medical device and technology company offering products and solutions related to the brain including neurology, AI and...
Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application for Cenobamate
March 26, 2020 09:23 ET
|
Arvelle Therapeutics
Arvelle Announces European Medicines Agency Acceptance of the Marketing Authorization Application (MAA) for Cenobamate The MAA seeks authorisation for the adjunctive treatment of focal-onset...